Speech Perception Impairment Follow Complete Recovery of Sudden Sensorineural Hearing Loss
Correlation Between Peripheral Hearing Loss and Auditory Perception Impairment in Patients With Unilateral Sudden Deafness and Its Underlying Neural Mechanism
1 other identifier
observational
10
0 countries
N/A
Brief Summary
At present, few research on the auditory perception function and possible neural mechanisms of unilateral sudden hearing loss patients with complete or partial recovery of peripheral hearing.This project evaluate the speech perception function in noise of unilateral sudden hearing loss patients with with complete and partial hearing recovery by cognitive behavioral experiments, event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI), and longitudinal follow-up to explore its underlying neural mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2022
CompletedFirst Posted
Study publicly available on registry
November 8, 2022
CompletedStudy Start
First participant enrolled
November 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedNovember 8, 2022
November 1, 2022
6 months
May 11, 2022
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Noisy speech recognition rate
The proportion of subjects correctly identifying the target sentence under different masking conditions and different signal-to-noise ratio conditions.
Change from Baseline Noisy speech recognition rate at admission,6 months, 12 months and 18 months after hearing recovery
Study Arms (2)
Patients with unilateral sudden deafness with complete recovery of peripheral hearing
The patients who recovered from sudden deafness underwent speech recognition rate tests under different masking conditions and different signal-to-noise ratio conditions within 2 weeks after complete recovery of peripheral hearing and were followed up 3 times at 1, 6, and 12 months after recovery. The test content is the same as the first time.
Healthy control group
Age-, gender-, and educational-matched healthy controls were enrolled as healthy control group to test speech recognition rates under different masking conditions and different signal-to-noise ratio conditions.
Interventions
The noise masker was a stream of steady-state speech-spectrum noise, whose spectrum was representative of the average spectrum of target sentences. The speech masker was a 47-s loop of digitally combined continuous recordings for Chinese nonsense sentences. Patients from the idiopathic sudden sensorineural hearing loss (ISSNHL) group and control group were tested bilateral (left, right) speech-in-noise (SIN) perception of various signal-to-noise ratios (SNRs) under speech and noise masking conditions. Each participant has to complete four consequent levels of SNRs (-12, -8, -4, 0 decibel (dB) for most of control group, -8, -4, 0, 4 dB for ISSNHL group). In addition, the benefits of spatial separation cues under these two types of masking were analyzed.
Eligibility Criteria
Patients with unilateral sudden sensorineural hearing loss who was treated in the outpatient department of our hospital.
You may qualify if:
- years old;
- patients with unilateral idiopathic sudden sensorineural hearing loss (at least three adjacent frequencies of hearing loss ≥ 30 dB );
- the first onset;
- Contralateral hearing is normal; 5) Hearing is cured after treatment
You may not qualify if:
- Sudden deafness with possible definite etiology, such as Meniere's disease, large vestibular aqueduct syndrome, trauma, retrocochlear tumor, etc.;
- Severe underlying diseases, heart disease, blood disease, pregnancy, breastfeeding, etc.;
- Suffering from other central diseases that may affect speech perception disorders, such as Alzheimer's disease, etc.;
- Those who cannot cooperate with the whole study inspection;
- Those who do not agree to be enrolled or refuse to sign the informed consent form;
- Those who are using may affect the Medications or treatments for speech perception disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- chief physician
Study Record Dates
First Submitted
May 11, 2022
First Posted
November 8, 2022
Study Start
November 10, 2022
Primary Completion
May 10, 2023
Study Completion
May 31, 2023
Last Updated
November 8, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share